MTOR and autosomal dominant polycystic kidney disease: Key molecular pathways implicated in ADPKD pathogenesis include the mammalian target of rapamycin (mTOR), cyclic AMP (cAMP), and Wnt signaling pathways/but numerous others have been identified [15].